CONCORD HC GP (02453) released its interim results, reporting a loss attributable to shareholders of 77.338 million yuan, a year-on-year reduction of 56.2%.

CONCORD HC GP (02453) announced its results for the six months ending June 30, 2026, with revenue of 270 million yuan, representing a year-on-year increase of 34.2%; the loss attributable to owners narrowed to 77.338 million yuan, a decrease of 56.2% year-on-year; basic loss per share was 9.87 cents. Revenue from hospital operations increased by 73.4% year-on-year to 265.7 million yuan, primarily due to a significant increase in revenue from proton therapy services at the Guangzhou hospital, which also boosted income from other medical services. Revenue from medical equipment, software, and related services decreased by 91.6% year-on-year to 4 million yuan, mainly due to a delay in overall business demand in the current macroeconomic environment.